Disrupted cross-laminar cortical processing in β amyloid pathology precedes cell death
Disruption of neuronal networks in the Alzheimer-afflicted brain is increasingly recognized as a key correlate of cognitive and memory decline in Alzheimer patients. We hypothesized that functional synaptic disconnections within cortical columnar microcircuits by pathological β-amyloid accumulation,...
Main Authors: | H. Lison, M.F.K. Happel, F. Schneider, K. Baldauf, S. Kerbstat, B. Seelbinder, J. Schneeberg, M. Zappe, J. Goldschmidt, E. Budinger, U.H. Schröder, F.W. Ohl, S. Schilling, H.-U. Demuth, H. Scheich, K.G. Reymann, R. Rönicke |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-03-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996113003276 |
Similar Items
-
The Bacteroidetes Q-Rule: Pyroglutamate in Signal Peptidase I Substrates
by: Matthias Bochtler, et al.
Published: (2018-03-01) -
Immunohistochemical Evidence from APP-Transgenic Mice for Glutaminyl Cyclase as Drug Target to Diminish pE-Abeta Formation
by: Maike Hartlage-Rübsamen, et al.
Published: (2018-04-01) -
Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer’s disease: results of a randomized, double-blind, placebo-controlled phase 2a study
by: Philip Scheltens, et al.
Published: (2018-10-01) -
Natural Products from Microalgae with Potential against Alzheimer’s Disease: Sulfolipids Are Potent Glutaminyl Cyclase Inhibitors
by: Stephanie Hielscher-Michael, et al.
Published: (2016-11-01) -
Repurposing FDA‐Approved Compounds for the Discovery of Glutaminyl Cyclase Inhibitors as Drugs Against Alzheimer's Disease
by: Dr. Chenshu Xu, et al.
Published: (2021-09-01)